Scientists crack bacteria quantification challenge in quest for novel infection therapies
Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility
Dr. Dennis Nurjadi discusses the cell counting technology that has brought his team accuracy and reproducibility
This is the company's third diagnostic test to receive Emergency Use Authorization by U.S. FDA for detecting COVID-19
Join us on Monday, July 20, to discover the benefits of in-solution equilibrium affinity experiments using Gyrolab systems
Starts Monday, July 6. Register for free today to stay informed on the latest techniques and technologies for COVID-19 and infectious disease research
Join us on Thursday, July 16, to learn about the landscape for COVID-19 testing, the latest methods and tests, and the current state of regulations
The platform aims to deliver rapid and automated processing of human blood and blood products to obtain purified populations of immune cells
binx health’s proven molecular io platform combined with SHERLOCK CRISPR technology will enable rapid, accurate testing for SARS-CoV-2 in retail and near-patient settings
Only IgG assay from top four in vitro diagnostic manufacturers that detects antibodies targeting the receptor binding domain on the spike protein
More than 305,000 high-resolution, multi-channel COVID-19 cellular images are now available to the scientific community
The partnership aims to provide accessible solutions for labs involved in COVID-19 testing
Intended for use by clinical laboratories and diagnostic manufacturers, the panel aims to evaluate SARS-CoV-2 antibody assays
Key topics to include COVID-19 and infectious diseases, diabetes, sepsis, cardiovascular disease and personalized medicine as the global clinical community comes together to make the future healthier
The Oncomine Dx target test aims to identify HER2 gene mutations in non-small lung cancer patients
Clover Biopharmaceuticals initiates phase 1 study using GSK pandemic adjuvant in combination with COVID-19 vaccine candidate SCB-2019
Investment in state-of-the-art automation cements Abingdon Health’s position as a leading global rapid test manufacturer
Our new expert webinar series aims to help you get the most from your microbiology research
The company is providing well-characterized and standardized human primary cells with matching specialty cell culture media